An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects. In an onsite interview with CURE at the 2025 ASH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback